Mesoblast | MSB - Despesas De Vendas E Administração

Preço das Ações
2.14
Mudança Diária
-0.05 -2.28%
Mensal
0%
Anual
19.55%
Q2 Previsão
2.15




Despesas De Vendas E Administração Alterar Data
Avita Medical AUD 19.03M 1.95M 2025-12
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
CSL USD 1.23B 498M 2025-12
Pacific Edge NZD 19.17M 1.32M 2025-12
Paradigm Biopharmaceuticals AUD 2.83M 1.22M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Starpharma Holdings AUD 4.42M 2.86M 2025-12
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12